Eli Lilly Hits Fresh 52-Week High as Healthcare Sector Gains 3%

LLY•2026-06-26

Eli Lilly reached a fresh 52-week high on Friday as healthcare stocks outpaced the S&P 500, with the sector up around 3% year-to-date. The Health Care Select Sector ETF also climbed roughly 3%, reflecting defensive rotation that propelled big pharma names to new highs.

1. Lilly Surges to New High

On June 26 Eli Lilly shares closed at their highest level of the past year, marking a fresh 52-week high. Renewed investor interest in established pharmaceutical names underpinned the rally as the market sought defensive exposure.

2. Healthcare Sector Outperformance

Healthcare stocks in the S&P 500 have gained about 3% year-to-date, outpacing the broader index. Robust demand for stable revenue streams and lower volatility drove this sector-wide strength.

3. ETF and Peer Rally

The Health Care Select Sector SPDR ETF climbed roughly 3% over the same period, mirroring gains in big pharma. Johnson & Johnson, AbbVie and Merck also reached or neared 52-week highs as investors rotated into defensive names.